NCT06464133Enrolling by invitation
Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis
Source: ClinicalTrials.gov · Last updated 24 Apr 2026
Brief summary (registry, in English)
The study, Investigation of Filaggrin Gene Mutations among Latinx patients with Atopic Dermatitis, will examine the association between pathogenic FLG LOF variants and AD in a new population of Latinx patients for which clinical and disease characteristics will be well-described.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 10 May 2024
- Start date
- 23 Jan 2025
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- University of Pennsylvania
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06464133
What you commit to
- Study type: Observational
- Planned participants: 300
- From 23 Jan 2025 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Established diagnosis of AD based on physician report of at least one-year duration
- Self-identification as Latino/Latinx or Hispanic
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.